health

Danish firm behind weight-loss drug Wegovy raises profit forecast to £15.3bn

By
1 Mins read
136
0
Share
Reading Time: < 1 minute

Strong sales of diabetes and weight loss drugs Ozempic and Wegovy have prompted the Danish pharmaceutical company Novo Nordisk to raise its 2024 profit forecast to up to £15.3bn, with supply shortages starting to ease. Read More

136
0
Share
Related posts
health

Families scour southern Mexico after 40 migrants vanished on a dangerous sea route

By
1 Mins read
Reading Time: < 1 minuteOn Christmas Eve 2024, Elianis Caridad Morejón Pérez, a young Cuban woman, told her mother by phone that she had put on a…
health

Scientists issue urgent warning about drinking TEA – as research reveals your kettle can release up to 3 billion dangerous microplastic particles into your cuppa

By
1 Mins read
Reading Time: < 1 minuteFor many Brits, the day doesn’t really start until that first cup of tea. Read More  
health

EFCC arraigns blessing CEO over alleged ₦36m fraud

By
1 Mins read
Reading Time: < 1 minute
Subscribe to our Blog

Let's stay in touch. Subscribe to our blog and get our best content in your inbox. 

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.